{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:55:42Z","timestamp":1784303742356,"version":"3.55.0"},"reference-count":195,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T00:00:00Z","timestamp":1683936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515111204"],"award-info":[{"award-number":["2021A1515111204"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013093","name":"Science and Technology Planning Project of Shenzen Municipality","doi-asserted-by":"publisher","award":["JCYJ20220531092609020"],"award-info":[{"award-number":["JCYJ20220531092609020"]}],"id":[{"id":"10.13039\/501100013093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["2020152"],"award-info":[{"award-number":["2020152"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["2022045"],"award-info":[{"award-number":["2022045"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["2020036"],"award-info":[{"award-number":["2020036"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","award":["A2021475"],"award-info":[{"award-number":["A2021475"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fundamental Research"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.fmre.2023.04.012","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T04:30:00Z","timestamp":1684211400000},"page":"1781-1794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Functions, mechanisms, and therapeutic implications of noncoding RNA in acute myeloid leukemia"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4325-9907","authenticated-orcid":false,"given":"Xiaokang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianrong","family":"Xun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhe","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kit Hang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fmre.2023.04.012_bib0001","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.fmre.2023.04.012_bib0002","first-page":"1","article-title":"Advances in acute myeloid leukemia","volume":"375","author":"Newell","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.fmre.2023.04.012_bib0003","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1182\/blood.2019001299","article-title":"Ready for prime time: Role for geriatric assessment to improve quality of care in hematology practice","volume":"134","author":"Klepin","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.fmre.2023.04.012_bib0004","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.fmre.2022.08.018","article-title":"Medical care of rare and undiagnosed diseases: Prospects and challenges","volume":"2","author":"Zsa","year":"2022","journal-title":"Fundam. Res."},{"key":"10.1016\/j.fmre.2023.04.012_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-022-00402-5","article-title":"Myelodysplastic syndromes","volume":"8","author":"Li","year":"2022","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.fmre.2023.04.012_bib0006","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMoa1112304","article-title":"Prognostic relevance of integrated genetic profiling in acute myeloid leukemia","volume":"366","author":"Patel","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.fmre.2023.04.012_bib0007","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1200\/JCO.2010.30.1820","article-title":"Therapeutic advances in acute myeloid leukemia","volume":"29","author":"Burnett","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.fmre.2023.04.012_bib0008","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3324\/haematol.2013.091819","article-title":"Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: Long-term results of the multicenter prospective LAM-2001 trial by the GOELAMS study group","volume":"99","author":"Bertoli","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.fmre.2023.04.012_bib0009","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1182\/blood-2017-12-818948","article-title":"The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia","volume":"131","author":"Stein","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.fmre.2023.04.012_bib0010","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1158\/2159-8290.CD-16-0313","article-title":"Efficacy and biological correlates of response in a phase II study of venetoclax monotherapy in patients with acute myelogenous leukemia","volume":"6","author":"Konopleva","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.fmre.2023.04.012_bib0011","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41571-021-00509-w","article-title":"Towards precision medicine for AML","volume":"18","author":"D\u00f6hner","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.fmre.2023.04.012_bib0012","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1126\/science.1108625","article-title":"Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution","volume":"308","author":"Cheng","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.fmre.2023.04.012_bib0013","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1126\/science.1138341","article-title":"RNA maps reveal new RNA classes and a possible function for pervasive transcription","volume":"316","author":"Kapranov","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.fmre.2023.04.012_bib0014","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1126\/science.1076311","article-title":"Cleavage of Scarecrow-like mRNA targets directed by a class of Arabidopsis miRNA","volume":"297","author":"Llave","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.fmre.2023.04.012_bib0015","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.fmre.2023.04.012_bib0016","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","article-title":"Noncoding RNA therapeutics - challenges and potential solutions","volume":"20","author":"Winkle","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.fmre.2023.04.012_bib0017","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1182\/blood-2016-10-697698","article-title":"MicroRNAs and acute myeloid leukemia: Therapeutic implications and emerging concepts","volume":"130","author":"Wallace","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.fmre.2023.04.012_bib0018","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.fmre.2023.04.012_bib0019","doi-asserted-by":"crossref","first-page":"11511","DOI":"10.1073\/pnas.1310144110","article-title":"miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia","volume":"110","author":"Chen","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.fmre.2023.04.012_bib0020","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/leu.2013.357","article-title":"miR-9 is a tumor suppressor in pediatric AML with t(8;21)","volume":"28","author":"Emmrich","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.fmre.2023.04.012_bib0021","first-page":"5611","article-title":"MicroRNA-10a\/b are regulators of myeloid differentiation and acute myeloid leukemia","volume":"15","author":"Bi","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.fmre.2023.04.012_bib0022","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.prp.2017.11.019","article-title":"Bone marrow miR-10a overexpression is associated with genetic events but not affects clinical outcome in acute myeloid leukemia","volume":"214","author":"Zhang","year":"2018","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.fmre.2023.04.012_bib0023","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ccr.2010.03.008","article-title":"Sp1\/NFkappaB\/HDAC\/miR-29b regulatory network in KIT-driven myeloid leukemia","volume":"17","author":"Liu","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.fmre.2023.04.012_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1179-y","article-title":"MiR-29b\/Sp1\/FUT4 axis modulates the malignancy of leukemia stem cells by regulating fucosylation via Wnt\/\u03b2-catenin pathway in acute myeloid leukemia","volume":"38","author":"Liu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.fmre.2023.04.012_bib0025","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.prp.2017.06.017","article-title":"Decreased expression of microRNA-122 is associated with an unfavorable prognosis in childhood acute myeloid leukemia and function analysis indicates a therapeutic potential","volume":"213","author":"Yang","year":"2017","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.fmre.2023.04.012_bib0026","first-page":"1490","article-title":"Long non\u2011coding RNA ZEB2\u2011AS1 affects cell proliferation and apoptosis via the miR\u2011122\u20115p\/PLK1 axis in acute myeloid leukemia","volume":"46","author":"Guan","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.fmre.2023.04.012_bib0027","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1182\/blood-2016-06-721027","article-title":"promotes -driven murine acute myeloid leukemia involving a -mediated non-cell-intrinsic mechanism","volume":"129","author":"Liu","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.fmre.2023.04.012_bib0028","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/leu.2014.231","article-title":"NF-\u03baB\/STAT5\/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia","volume":"29","author":"Gerloff","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.fmre.2023.04.012_bib0029","doi-asserted-by":"crossref","first-page":"6608","DOI":"10.1093\/nar\/gkn666","article-title":"Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-\u03baB pathway","volume":"36","author":"Gatto","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.fmre.2023.04.012_bib0030","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1182\/blood-2010-03-272567","article-title":"MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: Rationale for treatment of NF-\u03baB-dependent lymphoma","volume":"116","author":"Milhollen","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.fmre.2023.04.012_bib0031","doi-asserted-by":"crossref","first-page":"15535","DOI":"10.1073\/pnas.0808266105","article-title":"Distinct microRNA expression profiles in acute myeloid leukemia with common translocations","volume":"105","author":"Li","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.fmre.2023.04.012_bib0032","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1182\/blood-2011-10-386235","article-title":"Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML","volume":"119","author":"Li","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.fmre.2023.04.012_bib0033","first-page":"197","article-title":"High level of miR-196b at newly diagnosed pediatric acute myeloid leukemia predicts a poor outcome","volume":"16","author":"Xu","year":"2017","journal-title":"Excli. J."},{"key":"10.1016\/j.fmre.2023.04.012_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cmet.2020.09.001","article-title":"Bone marrow mesenchymal stem cells support acute myeloid leukemia bioenergetics and enhance antioxidant defense and escape from chemotherapy","volume":"32","author":"Forte","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.fmre.2023.04.012_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep11295","article-title":"Serum exosome microRNA as a minimally-invasive early biomarker of AML","volume":"5","author":"Hornick","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.fmre.2023.04.012_bib0036","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s12015-017-9762-0","article-title":"Micro-RNA profiling of exosomes from marrow-derived mesenchymal stromal cells in patients with acute myeloid leukemia: Implications in leukemogenesis","volume":"13","author":"Barrera-Ramirez","year":"2017","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.fmre.2023.04.012_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scisignal.aaf2797","article-title":"AML suppresses hematopoiesis by releasing exosomes that contain microRNAs targeting c-MYB","volume":"9","author":"Hornick","year":"2016","journal-title":"Sci. Signal."},{"key":"10.1016\/j.fmre.2023.04.012_bib0038","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3324\/haematol.2015.134932","article-title":"Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms","volume":"101","author":"Horiguchi","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.fmre.2023.04.012_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-022-01193-0","article-title":"The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting","volume":"8","author":"Chen","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.fmre.2023.04.012_bib0040","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/s41375-018-0015-2","article-title":"miR-34c-5p promotes eradication of acute myeloid leukemia stem cells by inducing senescence through selective RAB27B targeting to inhibit exosome shedding","volume":"32","author":"Peng","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.fmre.2023.04.012_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biom12101448","article-title":"Exosomal miR92a promotes cytarabine resistance in myelodysplastic syndromes by activating Wnt\/\u03b2-catenin signal pathway","volume":"12","author":"Li","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.fmre.2023.04.012_bib0042","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1373\/clinchem.2015.241190","article-title":"Current state of circulating microRNAs as cancer biomarkers","volume":"61","author":"He","year":"2015","journal-title":"Clin. Chem."},{"key":"10.1016\/j.fmre.2023.04.012_bib0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fgene.2013.00119","article-title":"Circulating miRNAs: Cell-cell communication function?","volume":"4","author":"Turchinovich","year":"2013","journal-title":"Front. Genet."},{"key":"10.1016\/j.fmre.2023.04.012_bib0044","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1002\/jcp.26171","article-title":"Overexpression of miR-216b: Prognostic and predictive value in acute myeloid leukemia","volume":"233","author":"Zhang","year":"2018","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.fmre.2023.04.012_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-018-1445-3","article-title":"MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia","volume":"16","author":"Ma","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.fmre.2023.04.012_bib0046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bcj.2015.76","article-title":"The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia","volume":"5","author":"D\u00edaz-Bey\u00e1","year":"2015","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.fmre.2023.04.012_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13000-015-0345-6","article-title":"Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia","volume":"10","author":"Liu","year":"2015","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.fmre.2023.04.012_bib0048","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3233\/CBM-181381","article-title":"Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia","volume":"22","author":"Huang","year":"2018","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.fmre.2023.04.012_bib0049","first-page":"1134","article-title":"Downregulation of miR\u2011135a predicts poor prognosis in acute myeloid leukemia and regulates leukemia progression via modulating HOXA10 expression","volume":"18","author":"Xu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.fmre.2023.04.012_bib0050","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1002\/jcb.27679","article-title":"A 4-microRNA signature for survival prognosis in pediatric and adolescent acute myeloid leukemia","volume":"120","author":"Zhu","year":"2019","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.fmre.2023.04.012_bib0051","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1200\/JCO.2017.75.2204","article-title":"Endogenous tumor suppressor microRNA-193b: Therapeutic and prognostic value in acute myeloid leukemia","volume":"36","author":"Bhayadia","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.fmre.2023.04.012_bib0052","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3233\/CBM-170936","article-title":"Downregulated miR-217 expression predicts a poor outcome in acute myeloid leukemia","volume":"22","author":"Yan","year":"2018","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.fmre.2023.04.012_bib0053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-018-1647-8","article-title":"MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy","volume":"16","author":"Yang","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.fmre.2023.04.012_bib0054","doi-asserted-by":"crossref","first-page":"178","DOI":"10.7150\/jca.26391","article-title":"High expression of MiR-98 is a good prognostic factor in acute myeloid leukemia patients treated with chemotherapy alone","volume":"10","author":"Hu","year":"2019","journal-title":"J. Cancer"},{"key":"10.1016\/j.fmre.2023.04.012_bib0055","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1073\/pnas.1302645110","article-title":"Critical role of miR-9 in myelopoiesis and EVI1-induced leukemogenesis","volume":"110","author":"Senyuk","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.fmre.2023.04.012_bib0056","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1158\/0008-5472.CAN-09-3268","article-title":"The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression","volume":"70","author":"Wong","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.fmre.2023.04.012_bib0057","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1073\/pnas.0914900107","article-title":"Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia","volume":"107","author":"Mi","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.fmre.2023.04.012_bib0058","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.stem.2013.06.003","article-title":"The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation","volume":"13","author":"Song","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.fmre.2023.04.012_bib0059","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms11452","article-title":"miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia","volume":"7","author":"Jiang","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.fmre.2023.04.012_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pgen.1006259","article-title":"The PU.1-modulated microRNA-22 is a regulator of monocyte\/macrophage differentiation and acute myeloid leukemia","volume":"12","author":"Shen","year":"2016","journal-title":"PLoS Genet."},{"key":"10.1016\/j.fmre.2023.04.012_bib0061","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/cdd.2013.133","article-title":"The role, mechanism and potentially therapeutic application of microRNA-29 family in acute myeloid leukemia","volume":"21","author":"Gong","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.fmre.2023.04.012_bib0062","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1182\/blood-2009-03-211938","article-title":"MicroRNA 29b functions in acute myeloid leukemia","volume":"114","author":"Garzon","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.fmre.2023.04.012_bib0063","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.celrep.2013.08.050","article-title":"An extensive network of TET2-targeting MicroRNAs regulates malignant hematopoiesis","volume":"5","author":"Cheng","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.fmre.2023.04.012_bib0064","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1084\/jem.20080285","article-title":"Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation","volume":"205","author":"Bousquet","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.fmre.2023.04.012_bib0065","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1073\/pnas.1200677109","article-title":"Oncomir miR-125b regulates hematopoiesis by targeting the gene Lin28A","volume":"109","author":"Chaudhuri","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.fmre.2023.04.012_bib0066","doi-asserted-by":"crossref","first-page":"14235","DOI":"10.1073\/pnas.1009798107","article-title":"MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output","volume":"107","author":"O'Connell","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.fmre.2023.04.012_bib0067","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1182\/blood-2014-02-553842","article-title":"Dual mechanisms by which miR-125b represses IRF4 to induce myeloid and B-cell leukemias","volume":"124","author":"So","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.fmre.2023.04.012_bib0068","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1038\/leu.2015.139","article-title":"Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia","volume":"29","author":"Dorrance","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.fmre.2023.04.012_bib0069","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1158\/0008-5472.CAN-13-1733","article-title":"Attenuation of microRNA-126 expression that drives CD34+38- stem\/progenitor cells in acute myeloid leukemia leads to tumor eradication","volume":"74","author":"de Leeuw","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.fmre.2023.04.012_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-021-01133-y","article-title":"Treatment-induced arteriolar revascularization and miR-126 enhancement in bone marrow niche protect leukemic stem cells in AML","volume":"14","author":"Zhang","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.fmre.2023.04.012_bib0071","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1182\/blood-2010-03-277012","article-title":"Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations","volume":"117","author":"Starczynowski","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.fmre.2023.04.012_bib0072","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nm.2054","article-title":"Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype","volume":"16","author":"Starczynowski","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.fmre.2023.04.012_bib0073","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.celrep.2014.07.062","article-title":"Myeloid malignancies with chromosome 5q deletions acquire a dependency on an intrachromosomal NF-\u03baB gene network","volume":"8","author":"Fang","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.fmre.2023.04.012_bib0074","doi-asserted-by":"crossref","first-page":"E7140","DOI":"10.1073\/pnas.1706833114","article-title":"Regulatory axis controls autoimmunity and myelopoiesis, but is dispensable for hematopoietic stem cell homeostasis and tumor suppression","volume":"114","author":"Magilnick","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.fmre.2023.04.012_bib0075","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1200\/JCO.2012.45.6228","article-title":"Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients","volume":"31","author":"Marcucci","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.fmre.2023.04.012_bib0076","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1182\/blood-2016-09-740209","article-title":"miR-155 promotes FLT3-ITD-induced myeloproliferative disease through inhibition of the interferon response","volume":"129","author":"Wallace","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.fmre.2023.04.012_bib0077","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1182\/blood-2012-07-444729","article-title":"Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN\/PI3K signal pathway","volume":"121","author":"Li","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.fmre.2023.04.012_bib0078","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1038\/onc.2011.62","article-title":"MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia","volume":"30","author":"Gao","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.fmre.2023.04.012_bib0079","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1182\/blood-2008-04-154310","article-title":"Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization","volume":"113","author":"Popovic","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.fmre.2023.04.012_bib0080","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1158\/1078-0432.CCR-22-1598","article-title":"miR-196b-TLR7\/8 signaling axis regulates innate immune signaling and myeloid maturation in DNMT3A-mutant AML","volume":"28","author":"Gamlen","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.fmre.2023.04.012_bib0081","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1182\/blood-2009-08-240101","article-title":"Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia","volume":"115","author":"Pulikkan","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.fmre.2023.04.012_bib0082","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcla.23096","article-title":"Low serum miR-223 expression predicts poor outcome in patients with acute myeloid leukemia","volume":"34","author":"Yu","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.fmre.2023.04.012_bib0083","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ccr.2007.09.020","article-title":"Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1\/ETO oncoprotein","volume":"12","author":"Fazi","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.fmre.2023.04.012_bib0084","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.cell.2013.02.012","article-title":"Long noncoding RNAs: Cellular address codes in development and disease","volume":"152","author":"Batista","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.fmre.2023.04.012_bib0085","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1182\/blood.V89.9.3323","article-title":"Acute myeloid leukemia in the elderly: Assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study","volume":"89","author":"Leith","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.fmre.2023.04.012_bib0086","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1182\/blood-2005-11-4354","article-title":"Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: Results from Cancer and Leukemia Group B 8461","volume":"108","author":"Farag","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.fmre.2023.04.012_bib0087","doi-asserted-by":"crossref","first-page":"18679","DOI":"10.1073\/pnas.1422050112","article-title":"Expression and prognostic impact of lncRNAs in acute myeloid leukemia","volume":"111","author":"Garzon","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.fmre.2023.04.012_bib0088","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00277-018-3315-8","article-title":"Long non-coding RNA taurine-upregulated gene 1 correlates with poor prognosis, induces cell proliferation, and represses cell apoptosis via targeting aurora kinase A in adult acute myeloid leukemia","volume":"97","author":"Wang","year":"2018","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.fmre.2023.04.012_bib0089","first-page":"3342","article-title":"Long noncoding RNA SNHG5 is up-regulated and serves as a potential prognostic biomarker in acute myeloid leukemia","volume":"22","author":"Li","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.fmre.2023.04.012_bib0090","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.2147\/CMAR.S180150","article-title":"Overexpression of lncRNA predicts adverse prognosis in acute myeloid leukemia","volume":"10","author":"Yang","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.fmre.2023.04.012_bib0091","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1089\/gtmb.2017.0281","article-title":"Low expression of long noncoding RNA IRAIN is associated with poor prognosis in non-M3 acute myeloid leukemia patients","volume":"22","author":"Pashaiefar","year":"2018","journal-title":"Genet. Test Mol. Biomarkers"},{"key":"10.1016\/j.fmre.2023.04.012_bib0092","doi-asserted-by":"crossref","first-page":"777","DOI":"10.4161\/rna.28828","article-title":"Long intergenic non-coding RNA HOTAIRM1 regulates cell cycle progression during myeloid maturation in NB4 human promyelocytic leukemia cells","volume":"11","author":"Zhang","year":"2014","journal-title":"RNA Biol."},{"key":"10.1016\/j.fmre.2023.04.012_bib0093","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-018-0941-x","article-title":"Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a\/EZH2\/Dnmts away from the HOXA1 gene in glioblastoma multiforme","volume":"37","author":"Li","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.fmre.2023.04.012_bib0094","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-14-693","article-title":"Inhibition of long non-coding RNA NEAT1 impairs myeloid differentiation in acute promyelocytic leukemia cells","volume":"14","author":"Zeng","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.fmre.2023.04.012_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-015-0223-4","article-title":"Overexpression of the long non-coding RNA PVT1 is correlated with leukemic cell proliferation in acute promyelocytic leukemia","volume":"8","author":"Zeng","year":"2015","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.fmre.2023.04.012_bib0096","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nature13311","article-title":"PVT1 dependence in cancer with MYC copy-number increase","volume":"512","author":"Tseng","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.fmre.2023.04.012_bib0097","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cddis.2017.526","article-title":"MYCN contributes to the malignant characteristics of erythroleukemia through EZH2-mediated epigenetic repression of p21","volume":"8","author":"Liu","year":"2017","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.fmre.2023.04.012_bib0098","first-page":"371","article-title":"Knockdown of long noncoding RNA plasmacytoma variant translocation 1 with antisense locked nucleic acid GapmeRs exerts tumor-suppressive functions in human acute erythroleukemia cells through downregulation of expression","volume":"34","author":"Salehi","year":"2019","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.fmre.2023.04.012_bib0099","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3892\/ijo.2016.3357","article-title":"Gene expression profiling of microRNAs associated with UCA1 in bladder cancer cells","volume":"48","author":"Xie","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.fmre.2023.04.012_bib0100","first-page":"763","article-title":"High expression of lnc-CRNDE presents as a biomarker for acute myeloid leukemia and promotes the malignant progression in acute myeloid leukemia cell line U937","volume":"22","author":"Wang","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.fmre.2023.04.012_bib0101","doi-asserted-by":"crossref","first-page":"9588","DOI":"10.1093\/nar\/gku549","article-title":"A novel antisense long noncoding RNA within the IGF1R gene locus is imprinted in hematopoietic malignancies","volume":"42","author":"Sun","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.fmre.2023.04.012_bib0102","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.etap.2017.08.014","article-title":"Long non-coding RNAs: The novel diagnostic biomarkers for leukemia","volume":"55","author":"Chen","year":"2017","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.fmre.2023.04.012_bib0103","first-page":"2233","article-title":"Long noncoding RNA UCA1 promotes cell proliferation, migration and invasion of human leukemia cells via sponging miR-126","volume":"22","author":"Sun","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.fmre.2023.04.012_bib0104","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","article-title":"Long noncoding RNA and cancer: A new paradigm","volume":"77","author":"Bhan","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.fmre.2023.04.012_bib0105","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1002\/ijc.28922","article-title":"An intragenic long noncoding RNA interacts epigenetically with the RUNX1 promoter and enhancer chromatin DNA in hematopoietic malignancies","volume":"135","author":"Wang","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.fmre.2023.04.012_bib0106","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1182\/blood-2008-06-162164","article-title":"A myelopoiesis-associated regulatory intergenic noncoding RNA transcript within the human HOXA cluster","volume":"113","author":"Zhang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.fmre.2023.04.012_bib0107","first-page":"1091","article-title":"Reciprocal regulation of chromatin state and architecture by HOTAIRM1 contributes to temporal collinear HOXA gene activation","volume":"45","author":"Wang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.fmre.2023.04.012_bib0108","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.febslet.2015.04.061","article-title":"Long non-coding RNA HOTAIR modulates c-KIT expression through sponging miR-193a in acute myeloid leukemia","volume":"589","author":"Xing","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.fmre.2023.04.012_bib0109","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/jcb.24586","article-title":"HOX antisense lincRNA HOXA-AS2 is an apoptosis repressor in all trans retinoic acid treated NB4 promyelocytic leukemia cells","volume":"114","author":"Zhao","year":"2013","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.fmre.2023.04.012_bib0110","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1101\/gad.1654808","article-title":"PU.1 expression is modulated by the balance of functional sense and antisense RNAs regulated by a shared cis-regulatory element","volume":"22","author":"Ebralidze","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.fmre.2023.04.012_bib0111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0119837","article-title":"Hypoxia-sensitive epigenetic regulation of an antisense-oriented lncRNA controls WT1 expression in myeloid leukemia cells","volume":"10","author":"McCarty","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.fmre.2023.04.012_bib0112","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1182\/blood-2006-06-027987","article-title":"EGO, a novel, noncoding RNA gene, regulates eosinophil granule protein transcript expression","volume":"109","author":"Wagner","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.fmre.2023.04.012_bib0113","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1038\/onc.2014.131","article-title":"A long noncoding RNA critically regulates Bcr-Abl-mediated cellular transformation by acting as a competitive endogenous RNA","volume":"34","author":"Guo","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.fmre.2023.04.012_bib0114","doi-asserted-by":"crossref","first-page":"330","DOI":"10.14348\/molcells.2016.2308","article-title":"Long non-coding RNA CCAT1 acts as a competing endogenous RNA to regulate cell growth and differentiation in acute myeloid leukemia","volume":"39","author":"Chen","year":"2016","journal-title":"Mol. Cells"},{"key":"10.1016\/j.fmre.2023.04.012_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-015-0364-7","article-title":"Long noncoding RNA, CCDC26, controls myeloid leukemia cell growth through regulation of KIT expression","volume":"14","author":"Hirano","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.fmre.2023.04.012_bib0116","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3892\/ijmm.2017.2888","article-title":"lncRNA co-expression network model for the prognostic analysis of acute myeloid leukemia","volume":"39","author":"Pan","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.fmre.2023.04.012_bib0117","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.3892\/mmr.2017.7029","article-title":"LncRNA H19 regulates ID2 expression through competitive binding to hsa-miR-19a\/b in acute myelocytic leukemia","volume":"16","author":"Zhao","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.fmre.2023.04.012_bib0118","first-page":"268","article-title":"LncRNA TP73-AS1 regulates miR-21\/PTEN axis to affect cell proliferation in acute myeloid leukemia","volume":"36","author":"Yuan","year":"2021","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.fmre.2023.04.012_bib0119","first-page":"1","article-title":"LncRNA GAS5 induces cell apoptosis in acute myeloid leukemia by targeting Nrf2","volume":"2022","author":"Qin","year":"2022","journal-title":"Dis. Markers"},{"key":"10.1016\/j.fmre.2023.04.012_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mco2.141","article-title":"LncRNAs and CircRNAs in cancer","volume":"3","author":"Yin","year":"2022","journal-title":"MedComm"},{"key":"10.1016\/j.fmre.2023.04.012_bib0121","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1261\/rna.047126.114","article-title":"Circular RNAs: Diversity of form and function","volume":"20","author":"Lasda","year":"2014","journal-title":"RNA"},{"key":"10.1016\/j.fmre.2023.04.012_bib0122","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1126\/science.1238522","article-title":"Molecular biology. A circuitous route to noncoding RNA","volume":"340","author":"Wilusz","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.fmre.2023.04.012_bib0123","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cell.2016.03.020","article-title":"Oncogenic role of fusion-circRNAs derived from cancer-associated chromosomal translocations","volume":"165","author":"Guarnerio","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.fmre.2023.04.012_bib0124","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1261\/rna.035667.112","article-title":"Circular RNAs are abundant, conserved, and associated with ALU repeats","volume":"19","author":"Jeck","year":"2013","journal-title":"RNA"},{"key":"10.1016\/j.fmre.2023.04.012_bib0125","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.molcel.2015.03.027","article-title":"Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed","volume":"58","author":"Rybak-Wolf","year":"2015","journal-title":"Mol. Cell."},{"key":"10.1016\/j.fmre.2023.04.012_bib0126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7717\/peerj.5503","article-title":"A comprehensive review of circRNA: From purification and identification to disease marker potential","volume":"6","author":"Xu","year":"2018","journal-title":"PeerJ"},{"key":"10.1016\/j.fmre.2023.04.012_bib0127","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature11928","article-title":"Circular RNAs are a large class of animal RNAs with regulatory potency","volume":"495","author":"Memczak","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.fmre.2023.04.012_bib0128","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.celrep.2016.03.058","article-title":"The biogenesis of nascent circular RNAs","volume":"15","author":"Zhang","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.fmre.2023.04.012_bib0129","first-page":"1","article-title":"Characterization of hsa_circ_0004277 as a new biomarker for acute myeloid leukemia via circular rna profile and bioinformatics analysis","volume":"18","author":"Li","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.fmre.2023.04.012_bib0130","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1038\/s41375-018-0033-0","article-title":"MYC-containing amplicons in acute myeloid leukemia: Genomic structures, evolution, and transcriptional consequences","volume":"32","author":"Abbate","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.fmre.2023.04.012_bib0131","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.3324\/haematol.2017.172866","article-title":"Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia","volume":"102","author":"Hirsch","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.fmre.2023.04.012_bib0132","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/hon.2829","article-title":"Hsa_circ_0002483 regulates miR-758-3p\/MYC axis to promote acute myeloid leukemia progression","volume":"39","author":"Xiao","year":"2021","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.fmre.2023.04.012_bib0133","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1002\/jcp.27145","article-title":"Circular RNA of vimentin expression as a valuable predictor for acute myeloid leukemia development and prognosis","volume":"234","author":"Yi","year":"2019","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.fmre.2023.04.012_bib0134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-5967-8","article-title":"Circ-Foxo3 is positively associated with the Foxo3 gene and leads to better prognosis of acute myeloid leukemia patients","volume":"19","author":"Zhou","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.fmre.2023.04.012_bib0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bcmd.2018.12.006","article-title":"Silencing of circ_0009910 inhibits acute myeloid leukemia cell growth through increasing miR-20a-5p","volume":"75","author":"Ping","year":"2019","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.fmre.2023.04.012_bib0136","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1159\/000491468","article-title":"Circ-ANAPC7 is upregulated in acute myeloid leukemia and appears to target the MiR-181 family","volume":"47","author":"Chen","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.fmre.2023.04.012_bib0137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-018-1726-x","article-title":"Circular RNA regulatory network reveals cell-cell crosstalk in acute myeloid leukemia extramedullary infiltration","volume":"16","author":"Lv","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.fmre.2023.04.012_bib0138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2018.10.011","article-title":"CircPAN3 mediates drug resistance in acute myeloid leukemia through the miR-153-5p\/miR-183-5p-XIAP axis","volume":"70","author":"Shang","year":"2019","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.fmre.2023.04.012_bib0139","first-page":"1683","article-title":"Circular RNA profile of acute myeloid leukaemia indicates circular RNA annexin A2 as a potential biomarker and therapeutic target for acute myeloid leukaemia","volume":"12","author":"Ding","year":"2020","journal-title":"Am. J. Transl. Res."},{"issue":"20","key":"10.1016\/j.fmre.2023.04.012_bib0140","doi-asserted-by":"crossref","first-page":"e00259-18","DOI":"10.1128\/MCB.00259-18","article-title":"Role of circular RNA DLEU2 in human acute myeloid leukemia","volume":"38","author":"Wu","year":"2018","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.fmre.2023.04.012_bib0141","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109619","article-title":"A novel circular RNA (hsa_circ_0000370) increases cell viability and inhibits apoptosis of FLT3-ITD-positive acute myeloid leukemia cells by regulating miR-1299 and S100A7A","volume":"122","author":"Zhang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.fmre.2023.04.012_bib0142","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1182\/blood.2019000802","article-title":"CircMYBL2, a circRNA from MYBL2, regulates FLT3 translation by recruiting PTBP1 to promote FLT3-ITD AML progression","volume":"134","author":"Sun","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.fmre.2023.04.012_bib0143","first-page":"9251","article-title":"Identification of non-coding RNA regulatory networks in pediatric acute myeloid leukemia reveals circ-0004136 could promote cell proliferation by sponging miR-142","volume":"23","author":"Yuan","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.fmre.2023.04.012_bib0144","article-title":"The regulation of circRNA RNF13\/miRNA-1224-5p axis promotes the malignant evolution in acute myeloid leukemia","volume":"2020","author":"Zhang","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.fmre.2023.04.012_bib0145","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s12094-020-02377-9","article-title":"Hsa_circ_0121582 inhibits leukemia growth by dampening Wnt\/\u03b2-catenin signaling","volume":"22","author":"Chen","year":"2020","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.fmre.2023.04.012_bib0146","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bbrc.2018.11.002","article-title":"Circular RNA-100290 promotes cell proliferation and inhibits apoptosis in acute myeloid leukemia cells via sponging miR-203","volume":"507","author":"Fan","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.fmre.2023.04.012_bib0147","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.18632\/aging.202240","article-title":"Hsa_circ_0079480 promotes tumor progression in acute myeloid leukemia via miR-654-3p\/HDGF axis","volume":"13","author":"Hu","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.fmre.2023.04.012_bib0148","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1002\/jcp.27393","article-title":"Long noncoding RNA NEAT1 modulates cell proliferation and apoptosis by regulating miR-23a-3p\/SMC1A in acute myeloid leukemia","volume":"234","author":"Zhao","year":"2019","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.fmre.2023.04.012_bib0149","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1002\/jcb.26899","article-title":"Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a\/hexokinase 2 pathway","volume":"119","author":"Zhang","year":"2018","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.fmre.2023.04.012_bib0150","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41419-020-03193-3","article-title":"Long noncoding RNA HOXA-AS2 functions as an oncogene by binding to EZH2 and suppressing LATS2 in acute myeloid leukemia (AML)","volume":"11","author":"Feng","year":"2020","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.fmre.2023.04.012_bib0151","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1159\/000495387","article-title":"Knockdown of long noncoding RNA HOXA-AS2 suppresses chemoresistance of acute myeloid leukemia via the miR-520c-3p\/S100A4 axis","volume":"51","author":"Dong","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.fmre.2023.04.012_bib0152","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13045-016-0274-1","article-title":"PU.1 controls the expression of long noncoding RNA HOTAIRM1 during granulocytic differentiation","volume":"9","author":"Wei","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.fmre.2023.04.012_bib0153","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41419-018-0699-2","article-title":"Profiling and functional analysis of circular RNAs in acute promyelocytic leukemia and their dynamic regulation during all-trans retinoic acid treatment","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.fmre.2023.04.012_bib0154","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000520446","article-title":"Using circ-ANAPC7 as a novel type of biomarker in the monitoring of acute myeloid leukemia","volume":"145","author":"Shen","year":"2022","journal-title":"Acta Haematol."},{"key":"10.1016\/j.fmre.2023.04.012_bib0155","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1182\/blood-2012-03-413898","article-title":"Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia","volume":"119","author":"Blum","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.fmre.2023.04.012_bib0156","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00277-019-03887-5","article-title":"MicroRNAs: Pivotal regulators in acute myeloid leukemia","volume":"99","author":"Li","year":"2020","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.fmre.2023.04.012_bib0157","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/leu.2015.106","article-title":"Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia","volume":"29","author":"Khalife","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.fmre.2023.04.012_bib0158","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1182\/blood-2008-07-170589","article-title":"MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1","volume":"113","author":"Garzon","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.fmre.2023.04.012_bib0159","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1182\/blood-2007-08-110171","article-title":"Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1\/NF-kappaB-dependent DNA methyltransferase activity in acute myeloid leukemia","volume":"111","author":"Liu","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.fmre.2023.04.012_bib0160","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.biomaterials.2018.03.013","article-title":"Targeting epigenetic pathway with gold nanoparticles for acute myeloid leukemia therapy","volume":"167","author":"Deng","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.fmre.2023.04.012_bib0161","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12885-018-4097-z","article-title":"A novel miR-375-HOXB3-CDCA3\/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia","volume":"18","author":"Bi","year":"2018","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.fmre.2023.04.012_bib0162","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10428194.2016.1272680","article-title":"MicroRNAs and tRNA-derived fragments predict the transformation of myelodysplastic syndromes to acute myeloid leukemia","volume":"58","author":"Guo","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.fmre.2023.04.012_bib0163","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1182\/blood-2012-06-435669","article-title":"Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: Results of the United Kingdom MRC AML-15 trial","volume":"120","author":"Yin","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.fmre.2023.04.012_bib0164","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/leu.2017.113","article-title":"Measurable residual disease testing in acute myeloid leukaemia","volume":"31","author":"Hourigan","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.fmre.2023.04.012_bib0165","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-virology-110615-042409","article-title":"Unraveling the mysterious interactions between hepatitis C virus RNA and liver-specific microRNA-122","volume":"3","author":"Sarnow","year":"2016","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.fmre.2023.04.012_bib0166","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s41419-021-03767-9","article-title":"LncRNA CD27-AS1 promotes acute myeloid leukemia progression through the miR-224-5p\/PBX3 signaling circuit","volume":"12","author":"Tao","year":"2021","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.fmre.2023.04.012_bib0167","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1111\/cas.13792","article-title":"Tumor suppressive role for kinases phosphorylating p53 in DNA damage-induced apoptosis","volume":"109","author":"Yogosawa","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.fmre.2023.04.012_bib0168","doi-asserted-by":"crossref","first-page":"5770","DOI":"10.1038\/onc.2016.110","article-title":"Long non-coding RNA SNHG5 suppresses gastric cancer progression by trapping MTA2 in the cytosol","volume":"35","author":"Zhao","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.fmre.2023.04.012_bib0169","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109802","article-title":"Long non-coding RNA SNHG5 regulates chemotherapy resistance through the miR-32\/DNAJB9 axis in acute myeloid leukemia","volume":"123","author":"Wang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.fmre.2023.04.012_bib0170","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41420-022-01174-3","article-title":"Functions and underlying mechanisms of lncRNA HOTAIR in cancer chemotherapy resistance","volume":"8","author":"Zhu","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.fmre.2023.04.012_bib0171","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13046-020-01610-1","article-title":"LncRNA HOTAIR-mediated MTHFR methylation inhibits 5-fluorouracil sensitivity in esophageal cancer cells","volume":"39","author":"Zhang","year":"2020","journal-title":"J. Exp. Clin. Cancer. Res."},{"key":"10.1016\/j.fmre.2023.04.012_bib0172","doi-asserted-by":"crossref","first-page":"e483","DOI":"10.1038\/bcj.2016.81","article-title":"CircRNAs in hematopoiesis and hematological malignancies","volume":"6","author":"Bonizzato","year":"2016","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.fmre.2023.04.012_bib0173","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2217\/epi-2019-0352","article-title":"suppresses acute myeloid leukemia progression via targeting \/axis","volume":"12","author":"Han","year":"2020","journal-title":"Epigenomics"},{"key":"10.1016\/j.fmre.2023.04.012_bib0174","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1182\/bloodadvances.2019000568","article-title":"Clinical and functional significance of circular RNAs in cytogenetically normal AML","volume":"4","author":"Papaioannou","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.fmre.2023.04.012_bib0175","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bbrc.2022.02.087","article-title":"Expression profiling of N-methyladenosine modified circRNAs in acute myeloid leukemia","volume":"601","author":"Issah","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.fmre.2023.04.012_bib0176","first-page":"59","article-title":"Epigenetic modifications in acute myeloid leukemia: The emerging role of circular RNAs (Review)","author":"Issah","year":"2021","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.fmre.2023.04.012_bib0177","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lungcan.2017.04.021","article-title":"Surgery Versus chemotherapy and radiotherapy for early and locally advanced small cell lung cancer: A propensity-matched analysis of survival","volume":"109","author":"Wakeam","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.fmre.2023.04.012_bib0178","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2016.06.006","article-title":"The bad seed: Cancer stem cells in tumor development and resistance","volume":"28","author":"Koren","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.fmre.2023.04.012_bib0179","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9277360","article-title":"LncRNA CARMN affects hepatocellular carcinoma prognosis by regulating the miR-192-5p\/LOXL2 axis","volume":"2022","author":"Wang","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.fmre.2023.04.012_bib0180","article-title":"Inflammatory signaling on cytochrome P450-mediated drug metabolism in hepatocytes","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.fmre.2023.04.012_bib0181","article-title":"Construction of a survival nomogram for gastric cancer based on the cancer genome atlas of m6A-related genes","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.fmre.2023.04.012_bib0182","doi-asserted-by":"crossref","first-page":"10897","DOI":"10.1039\/C9RA00306A","article-title":"TUG1 knockdown enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant acute myeloid leukemia HL60\/ADR cells","volume":"9","author":"Chen","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.fmre.2023.04.012_bib0183","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.stem.2015.06.006","article-title":"Tetraspanin 3 is required for the development and propagation of acute myelogenous leukemia","volume":"17","author":"Kwon","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.fmre.2023.04.012_bib0184","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1093\/nar\/gkz1168","article-title":"The conserved 3\u2032 UTR-derived small RNA NarS mediates mRNA crossregulation during nitrate respiration","volume":"48","author":"Wang","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.fmre.2023.04.012_bib0185","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1208760","article-title":"Safety and efficacy of RNAi therapy for transthyretin amyloidosis","volume":"369","author":"Coelho","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.fmre.2023.04.012_bib0186","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s11095-017-2134-2","article-title":"The race of 10 synthetic RNAi-based drugs to the pharmaceutical market","volume":"34","author":"Titze-de-Almeida","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.fmre.2023.04.012_bib0187","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/jcmm.16110","article-title":"miR-15a-5p and miR-21-5p contribute to chemoresistance in cytogenetically normal acute myeloid leukaemia by targeting PDCD4, ARL2 and BTG2","volume":"25","author":"Vandewalle","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.fmre.2023.04.012_bib0188","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szak\u00e1cs","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.fmre.2023.04.012_bib0189","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10142-022-00950-9","article-title":"Tumor-suppressing effects of miR-381-3p in pediatric acute myeloid leukemia via ROCK1 downregulation","volume":"23","author":"Ye","year":"2023","journal-title":"Funct. Integr. Genomics"},{"key":"10.1016\/j.fmre.2023.04.012_bib0190","doi-asserted-by":"crossref","first-page":"e82062","DOI":"10.1371\/journal.pone.0082062","article-title":"Changes in the expression of miR-381 and miR-495 are inversely associated with the expression of the MDR1 gene and development of multi-drug resistance","volume":"8","author":"Xu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.fmre.2023.04.012_bib0191","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.leukres.2009.10.002","article-title":"miR-138 might reverse multidrug resistance of leukemia cells","volume":"34","author":"Zhao","year":"2010","journal-title":"Leuk. Res."},{"key":"10.1016\/j.fmre.2023.04.012_bib0192","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1111\/j.1582-4934.2010.01213.x","article-title":"Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia","volume":"15","author":"Feng","year":"2011","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.fmre.2023.04.012_bib0193","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00432-011-1137-3","article-title":"miR-181a sensitizes resistant leukaemia HL-60\/Ara-C cells to Ara-C by inducing apoptosis","volume":"138","author":"Bai","year":"2012","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.fmre.2023.04.012_bib0194","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7150\/thno.77404","article-title":"DNA hypermethylation-induced miR-182 silence targets BCL2 and HOXA9 to facilitate the self-renewal of leukemia stem cell, accelerate acute myeloid leukemia progression, and determine the sensitivity of BCL2 inhibitor venetoclax","volume":"13","author":"Ye","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.fmre.2023.04.012_bib0195","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/leu.2016.270","article-title":"Nuclear FOXM1 drives chemoresistance in AML","volume":"31","author":"Khan","year":"2017","journal-title":"Leukemia"}],"container-title":["Fundamental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667325823001309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667325823001309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T23:19:09Z","timestamp":1762643949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667325823001309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":195,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2667325823001309"],"URL":"https:\/\/doi.org\/10.1016\/j.fmre.2023.04.012","relation":{},"ISSN":["2667-3258"],"issn-type":[{"value":"2667-3258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functions, mechanisms, and therapeutic implications of noncoding RNA in acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Fundamental Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fmre.2023.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Publishing Services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}